US President Donald Trump has promised Arab and Muslim leaders that he will not allow Israel to annex the occupied West Bank, a move Benjamin Netanyahu’s government is considering in response to a ...

The new investment nearly triples Modular’s valuation since its last round in 2023. The $250mn financing was led by US Innovative Technology, the fund headed by former Legendary Entertainment owner ...

The EU regulator seeking to ban “forever chemicals” hired a consultancy that was also lobbying on behalf of chemical manufacturers, in a fresh reputational hit to the bloc’s environmental agenda.

Huang has said that for every 1 gigawatt of AI infrastructure deployed, as much as $50bn is spent on the computing hardware, including Nvidia’s specialised processors and its own networking technology ...

China will cut its greenhouse gas emissions by up to 10 per cent and increase renewable energy capacity six-fold within a decade, President Xi Jinping announced in a new climate plan, along with a ...

Citigroup has agreed to sell a 25 per cent stake in Mexico’s Banamex to financier Fernando Chico Pardo, bringing the Wall Street bank one step closer to a full divestiture of the retail bank.

A top Federal Reserve official has warned against launching a series of rate cuts, saying a sharp slowdown in the jobs market is not a sign that a recession is looming.

Labour mayor for Greater Manchester outlines plans including tax hikes on the wealthy and nationalisation of key industries ...

Britain must ‘turn the tide’ on loss of talent, says British Chambers of Commerce director-general Shevaun Haviland ...

Despite Trump’s professed support, the industry said it fears being caught in the crossfire of his attacks on renewable energy. Since taking office the White House has slashed Joe Biden-era tax ...

Also in today’s newsletter, Typhoon Ragasa leaves trail of destruction, and New Zealand appoints Swedish economist to lead central bank ...

The UK government wants to end a damaging feud with pharmaceutical companies and pay more for medicines “to get those companies back again”, Britain’s science minister has said.